SGLT2 Inhibitors and Their Mode of Action in Heart Failure—Has the Mystery Been Unravelled?

PURPOSE OF REVIEW: SGLT2 inhibitors (SGLT2i) are new drugs for patients with heart failure (HF) irrespective of diabetes. However, the mechanisms of SGLT2i in HF remain elusive. This article discusses the current clinical evidence for using SGLT2i in different types of heart failure and provides an...

Descripción completa

Detalles Bibliográficos
Autores principales: Pabel, Steffen, Hamdani, Nazha, Luedde, Mark, Sossalla, Samuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Translational Research in Heart Failure (E. Bertero, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484236/
https://www.ncbi.nlm.nih.gov/pubmed/34523061
http://dx.doi.org/10.1007/s11897-021-00529-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484236/
https://www.ncbi.nlm.nih.gov/pubmed/34523061
http://dx.doi.org/10.1007/s11897-021-00529-8

Ejemplares similares